Autologous exosome therapy

Autologous exosome therapy refers to the use of exosomes derived from platelets extracted from the patient’s own blood. This therapy is expected to produce multiple effects, such as promoting skin regeneration, treating hair loss, and enhancing the immune system. Autologous exosomes represent a cutting-edge technology in the field of cellular regeneration and repair.
When combined with cell-based therapies such as SVF or BMAC, even more significant results are anticipated.

Applied Technology: Intra-articular injection of autologous platelet-rich plasma for knee osteoarthritis. Evaluation Results: Intra-articular injection of autologous platelet-rich plasma for knee osteoarthritis is a safe and effective technique that relieves pain and improves joint function in patients with KL grade II–III knee osteoarthritis, especially those who have not responded to conventional treatments (oral medications and intra-articular injections of steroids or hyaluronic acid) for more than one year (evidence level B). The deliberation results of the New Health Technology Assessment Committee and the review findings of the subcommittee were reported to the Minister of Health and Welfare on September 9, 2024.